$ORGO
Organogenesis Holdings Inc. Stock $orgo

$orgo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024023150 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$110.0M	$99.65M	$433.1M
YoY Change	2.17%	-13.73%	-3.94%
Cost Of Revenue	$28.70M	$27.77M	$106.5M
YoY Change	7.85%	2.43%	1.39%
Gross Profit	$81.28M	$71.88M	$326.7M
YoY Change	0.3%	-18.69%	-5.56%
Gross Profit Margin	73.91%	72.13%	75.42%
Selling, General & Admin	$72.32M	$61.38M	$269.8M
YoY Change	-2.05%	-10.12%	-4.95%
% of Gross Profit	88.98%	85.39%	82.58%
Research & Development	$12.81M	$11.77M	$44.38M
YoY Change	14.35%	3.29%	11.61%
% of Gross Profit	15.76%	16.37%	13.59%
Depreciation & Amortization	$3.072M	$4.211M	$10.45M
YoY Change	14.03%	53.97%	78.75%
% of Gross Profit	3.78%	5.86%	3.2%
Operating Expenses	$85.13M	$73.15M	$314.1M
YoY Change	0.11%	-8.2%	-2.92%
Operating Profit	-$3.852M	-$1.269M	$12.53M
YoY Change	-3.72%	-114.56%	-43.84%
Interest Expense	$514.0K	-$502.0K	$2.190M
YoY Change	-20.8%	-1773.33%	9.01%
% of Operating Profit			17.49%
Other Income/Expense, Net	-$491.0K	-$25.00K	-$2.133M
YoY Change	-21.57%	-516.67%	5.49%
Pretax Income	-$4.343M	-$1.796M	$10.39M
YoY Change	-6.14%	-120.52%	-48.76%
Income Tax	-$2.243M	-$1.228M	$5.447M
% Of Pretax Income			52.42%
Net Earnings	-$2.100M	-$568.0K	$4.945M
YoY Change	-29.27%	-107.59%	-68.16%
Net Earnings / Revenue	-1.91%	-0.57%	1.14%
Basic Earnings Per Share	-$0.02		$0.04
Diluted Earnings Per Share	-$0.02	$0.00	$0.04
COMMON SHARES
Basic Shares Outstanding	132.0M	132.0M	131.2M
Diluted Shares Outstanding	131.9M		132.7M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$88.63M	$103.8M	$103.8M
YoY Change	-0.08%	1.33%	1.33%
Cash & Equivalents	$88.63M	$103.8M
Short-Term Investments
Other Short-Term Assets	$14.70M	$10.95M	$10.95M
YoY Change	39.09%	85.69%	85.69%
Inventory	$27.69M	$28.25M	$28.25M
Prepaid Expenses		$10.45M
Receivables	$96.15M	$82.00M	$82.00M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$227.2M	$225.0M	$225.0M
YoY Change	4.77%	1.09%	1.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$114.2M	$116.2M	$156.3M
YoY Change	7.13%	13.43%	7.34%
Goodwill	$28.77M	$28.77M
YoY Change	0.0%	0.0%
Intangibles	$14.97M	$15.87M
YoY Change	-23.47%	-23.66%
Long-Term Investments
YoY Change
Other Assets	$6.709M	$5.990M	$33.99M
YoY Change	358.58%	294.08%	7.79%
Total Long-Term Assets	$231.3M	$235.0M	$235.0M
YoY Change	0.88%	3.63%	3.63%
TOTAL ASSETS
Total Short-Term Assets	$227.2M	$225.0M	$225.0M
Total Long-Term Assets	$231.3M	$235.0M	$235.0M
Total Assets	$458.5M	$460.0M	$460.0M
YoY Change	2.77%	2.37%	2.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.23M	$30.72M	$30.72M
YoY Change	-23.36%	-4.97%	-4.97%
Accrued Expenses	$39.76M	$30.07M	$43.22M
YoY Change	39.03%	13.71%	13.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.592M	$6.567M	$6.567M
YoY Change	31.6%	44.71%	44.71%
Total Short-Term Liabilities	$82.80M	$80.51M	$80.51M
YoY Change	8.84%	7.31%	7.31%
LONG-TERM LIABILITIES
Long-Term Debt	$60.98M	$62.63M	$62.63M
YoY Change	-5.99%	-5.43%	-5.43%
Other Long-Term Liabilities	$1.242M	$1.213M	$38.22M
YoY Change	8.47%	8.11%	-9.93%
Total Long-Term Liabilities	$1.242M	$1.213M	$100.9M
YoY Change	8.47%	8.11%	-7.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$82.80M	$80.51M	$80.51M
Total Long-Term Liabilities	$1.242M	$1.213M	$100.9M
Total Liabilities	$180.5M	$181.4M	$181.4M
YoY Change	-1.07%	-1.27%	-1.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.07M	-$40.97M
YoY Change	-11.89%	-9.56%
Common Stock	$321.1M	$319.6M
YoY Change	2.72%	2.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$278.0M	$278.7M	$278.7M
YoY Change
Total Liabilities & Shareholders Equity	$458.5M	$460.0M	$460.0M
YoY Change	2.77%	2.37%	2.37%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.100M	-$568.0K	$4.945M
YoY Change	-29.27%	-107.59%	-68.16%
Depreciation, Depletion And Amortization	$3.072M	$4.211M	$10.45M
YoY Change	14.03%	53.97%	78.75%
Cash From Operating Activities	-$10.16M	$10.61M	$30.92M
YoY Change	100.16%	36.08%	24.37%
INVESTING ACTIVITIES
Capital Expenditures	$2.222M	$3.324M	$24.36M
YoY Change	-70.62%	-68.81%	-28.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$2.222M	-$3.324M	-$24.36M
YoY Change	-70.62%	-68.81%	-28.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.608M	-1.777M	-5.505M
YoY Change	111.0%	-5.23%	150.34%
NET CHANGE
Cash From Operating Activities	-10.16M	10.61M	30.92M
Cash From Investing Activities	-2.222M	-3.324M	-24.36M
Cash From Financing Activities	-2.608M	-1.777M	-5.505M
Net Change In Cash	-14.99M	5.513M	1.048M
YoY Change	8.05%	-216.53%	-109.33%
FREE CASH FLOW
Cash From Operating Activities	-$10.16M	$10.61M	$30.92M
Capital Expenditures	$2.222M	$3.324M	$24.36M
Free Cash Flow	-$12.38M	$7.290M	$6.553M
YoY Change	-2.02%	-355.25%	-172.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37906
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001661181
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2023	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member
CY2021	orgo	Effective Income Tax Rate Reconciliation State Tax Credit Percent EffectiveIncomeTaxRateReconciliationStateTaxCreditPercent
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentNet
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89450000
CY2023Q4	us-gaap	Inventory Net InventoryNet	28253000
CY2022Q4	us-gaap	Inventory Net InventoryNet	24783000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10454000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5086000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	225044000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	222609000
CY2023	dei	Entity Registrant Name EntityRegistrantName	ORGANOGENESIS HOLDINGS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1329150
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	85 Dan Road
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Canton
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02021
CY2023	dei	City Area Code CityAreaCode	781
CY2023	dei	Local Phone Number LocalPhoneNumber	575-0775
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.0001 par value
CY2023	dei	Trading Symbol TradingSymbol	ORGO
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	235700000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	131963176
CY2023	dei	Auditor Firm AuditorFirmId	49
CY2023	dei	Auditor Name AuditorName	RSM US LLP
CY2023	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103840000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102478000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	498000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	812000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81999000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116228000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102463000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15871000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20789000
CY2023Q4	us-gaap	Goodwill Goodwill	28772000
CY2022Q4	us-gaap	Goodwill Goodwill	28772000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	40118000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43192000
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	28002000
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	30014000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5990000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1520000
CY2023Q4	us-gaap	Assets Assets	460025000
CY2022Q4	us-gaap	Assets Assets	449359000
CY2023Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	5486000
CY2022Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	4538000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1081000
CY2023Q4	orgo	Current Portion Of Operating Lease Obligations Related Party CurrentPortionOfOperatingLeaseObligationsRelatedParty	3140000
CY2022Q4	orgo	Current Portion Of Operating Lease Obligations Related Party CurrentPortionOfOperatingLeaseObligationsRelatedParty	3001000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10004000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8707000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30724000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	32330000
CY2023Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	30074000
CY2022Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	26447000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	80509000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	75023000
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	60745000
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	66231000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1888000
CY2023Q4	orgo	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	17227000
CY2022Q4	orgo	Operating Lease Liability Noncurrent Related Party OperatingLeaseLiabilityNoncurrentRelatedParty	20367000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19780000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20947000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1213000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1122000
CY2023Q4	us-gaap	Liabilities Liabilities	181362000
CY2022Q4	us-gaap	Liabilities Liabilities	183690000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132044944
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	131647677
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	131316396
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	130919129
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	319621000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	310957000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40971000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-45301000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	278663000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	265669000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	460025000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	449359000
CY2023	us-gaap	Revenues Revenues	433140000
CY2022	us-gaap	Revenues Revenues	450893000
CY2021	us-gaap	Revenues Revenues	467359000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	106481000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	105019000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	114199000
CY2023	us-gaap	Gross Profit GrossProfit	326659000
CY2022	us-gaap	Gross Profit GrossProfit	345874000
CY2021	us-gaap	Gross Profit GrossProfit	353160000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	269754000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	283808000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	250200000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44380000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39762000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30742000
CY2023	us-gaap	Operating Expenses OperatingExpenses	314134000
CY2022	us-gaap	Operating Expenses OperatingExpenses	323570000
CY2021	us-gaap	Operating Expenses OperatingExpenses	280942000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	12525000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	22304000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	72218000
CY2023	us-gaap	Interest Expense InterestExpense	2190000
CY2022	us-gaap	Interest Expense InterestExpense	2009000
CY2021	us-gaap	Interest Expense InterestExpense	7236000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1883000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	57000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2133000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2022000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9132000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10392000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	20282000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63086000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5447000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4750000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31116000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4945000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	15532000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	94202000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.7
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131231317
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130070231
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128331022
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132746727
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132383152
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133662659
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	141808000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2198000
CY2021	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-737000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3864000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	241335000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2070000
CY2022	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-648000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6552000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	265669000
CY2023	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-332000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8996000
CY2023	us-gaap	Profit Loss ProfitLoss	4945000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	278663000
CY2023	us-gaap	Profit Loss ProfitLoss	4945000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2023	us-gaap	Depreciation Depreciation	10448000
CY2022	us-gaap	Depreciation Depreciation	5845000
CY2021	us-gaap	Depreciation Depreciation	5781000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4918000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4883000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4949000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8083000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7303000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	5946000
CY2023	orgo	Non Cash Interest Expense NonCashInterestExpense	427000
CY2022	orgo	Non Cash Interest Expense NonCashInterestExpense	434000
CY2021	orgo	Non Cash Interest Expense NonCashInterestExpense	346000
CY2023	orgo	Deferred Interest Expense DeferredInterestExpense	490000
CY2022	orgo	Deferred Interest Expense DeferredInterestExpense	501000
CY2021	orgo	Deferred Interest Expense DeferredInterestExpense	1493000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2012000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1980000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31976000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-235000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4482000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1407000
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-559000
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1297000
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	1781000
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	2999000
CY2023	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-6580000
CY2022	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-9648000
CY2021	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-12079000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8996000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	6552000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3864000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1883000
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-3985000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5539000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8770000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28654000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8179000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9410000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	9302000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10115000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	378000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	34000
CY2023	orgo	Increase Decrease In Amortization Of Lease Liabilities IncreaseDecreaseInAmortizationOfLeaseLiabilities	8439000
CY2022	orgo	Increase Decrease In Amortization Of Lease Liabilities IncreaseDecreaseInAmortizationOfLeaseLiabilities	7006000
CY2021	orgo	Increase Decrease In Amortization Of Lease Liabilities IncreaseDecreaseInAmortizationOfLeaseLiabilities	6156000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-108000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3260000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3847000
CY2023	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	3138000
CY2022	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-11850000
CY2021	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	9354000
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	91000
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	72000
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6065000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30917000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24859000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	61978000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24364000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33898000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31220000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24364000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33898000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31220000
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-10000000
CY2021	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-60000000
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	73174000
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4688000
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	2813000
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	938000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	485000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2630000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2070000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2198000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	332000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	648000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	737000
CY2022	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	608000
CY2021	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	483000
CY2021	orgo	Payment To Extinguish Debt PaymentToExtinguishDebt	1620000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5505000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2199000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1036000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1048000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11238000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29722000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103290000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114528000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84806000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104338000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	103290000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	114528000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5436000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2649000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	5787000
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	3052000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	1201000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	607000
CY2023	orgo	Cumulative Effect Adjustment For Adoption CumulativeEffectAdjustmentForAdoption	615000
CY2022	orgo	Deferred Acquisition Consideration And Earnout Liability For Business Acquisition DeferredAcquisitionConsiderationAndEarnoutLiabilityForBusinessAcquisition	828000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	841000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1928000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3750000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5869000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1350000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	53793000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	3454000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. In preparing the consolidated financial statements, the estimates and assumptions that management considers to be significant and that present the greatest amount of uncertainty include revenue recognition; sales returns and credit losses; inventory reserve; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived assets, and the valuation and recognition of stock-based compensation. Actual results and outcomes may differ significantly from those estimates and assumptions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	498000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	812000
CY2023	orgo	Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock	<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:77.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:38.312%;"></td> <td style="width:1.299%;"></td> <td style="width:60.39%;"></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Leasehold improvements</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_101cdb3b-2d12-490a-8ccb-bc3f314f418e;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lesser of the life of the lease or the economic life of the asset</span></span></span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Building</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">30</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Furniture and computers</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Equipment</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> - </span><span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> years</span></p></td> </tr> </table>
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	5623000
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	6654000
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3663000
CY2023	us-gaap	Revenues Revenues	433140000
CY2022	us-gaap	Revenues Revenues	450893000
CY2021	us-gaap	Revenues Revenues	467359000
CY2021	orgo	Change In Valuation Allowance ChangeInValuationAllowance	-48300000
CY2023	orgo	Recentlyadoptedaccountingpronouncementspolicytextblock Recentlyadoptedaccountingpronouncementspolicytextblock	<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_e9b41aea-66f4-42a0-87cb-00ce59eaf9e6;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">2016-13</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> ("ASC 326"). The FASB subsequently issued a few amendments to ASC 326. ASC 326 and all the related updates replace the incurred loss impairment methodology previously required under GAAP, with an expected loss methodology that requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> the standard as of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">January 1, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> using the modified retrospective method. Under this method, the Company applied the new credit loss measurement guidance to trade accounts receivable, the only financial asset of the Company that is impacted by ASC 326 and the related updates. The Company recorded a net reduction of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">615</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to the opening balance of retained earnings as the cumulative effect of initially applying the standard. Results for reporting periods beginning after January 1, 2023 are presented in accordance with ASC 326. Prior period amounts have not been restated and are reported in accordance with legacy GAAP requirements.</span></p>
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3782000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3782000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	88859000
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	95812000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6860000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6362000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81999000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89450000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5153000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1781000
CY2022	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-572000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6362000
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1297000
CY2023	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-1414000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6860000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12988000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12282000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	810000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1022000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14455000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11479000
CY2023Q4	us-gaap	Inventory Net InventoryNet	28253000
CY2022Q4	us-gaap	Inventory Net InventoryNet	24783000
CY2023	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	6580000
CY2022	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	9648000
CY2021	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	12079000
CY2023Q4	orgo	Prepaid Subscription PrepaidSubscription	5866000
CY2022Q4	orgo	Prepaid Subscription PrepaidSubscription	4211000
CY2023Q4	orgo	Prepaid Licensing Fee PrepaidLicensingFee	2368000
CY2023Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	945000
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	106000
CY2023Q4	orgo	Prepaid Deposits PrepaidDeposits	872000
CY2022Q4	orgo	Prepaid Deposits PrepaidDeposits	635000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	85000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	54000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	318000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	80000
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10454000
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5086000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	130347000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	99697000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	73186000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62798000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116228000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	102463000
CY2023	us-gaap	Depreciation Depreciation	10448000
CY2022	us-gaap	Depreciation Depreciation	5845000
CY2021	us-gaap	Depreciation Depreciation	5781000
CY2023	orgo	Costs Associated With Enterprise Resource Planning Implementation CostsAssociatedWithEnterpriseResourcePlanningImplementation	10891000
CY2022	orgo	Sale And Donation Charges Of Equipment Related To Construction In Progress SaleAndDonationChargesOfEquipmentRelatedToConstructionInProgress	4200000
CY2022	orgo	Cancellation Fees Related To Pause Of Construction Of Manufacturing Facility CancellationFeesRelatedToPauseOfConstructionOfManufacturingFacility	632000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023Q4	us-gaap	Goodwill Goodwill	28772000
CY2022Q4	us-gaap	Goodwill Goodwill	28772000
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58523000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	42652000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15871000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58523000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	37734000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20789000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4918000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4883000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4949000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3403000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3323000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3043000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2283000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1968000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1851000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15871000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18287000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17113000
CY2023Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3075000
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3320000
CY2023Q4	orgo	Accrued But Unpaid Lease Obligations And Interest Current AccruedButUnpaidLeaseObligationsAndInterestCurrent	2326000
CY2022Q4	orgo	Accrued But Unpaid Lease Obligations And Interest Current AccruedButUnpaidLeaseObligationsAndInterestCurrent	2463000
CY2023Q4	orgo	Accrued Milestone Payment Current AccruedMilestonePaymentCurrent	2500000
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2799000
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2625000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1087000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	926000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30074000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	26447000
CY2023Q1	orgo	Number Of Reduction In Employees NumberOfReductionInEmployees	71
CY2023Q1	orgo	Percentage Of Reduction In Employees PercentageOfReductionInEmployees	0.07
CY2023Q1	us-gaap	Severance Costs1 SeveranceCosts1	1609000
CY2023Q4	orgo	Number Of Reduction In Employees NumberOfReductionInEmployees	49
CY2023Q4	orgo	Percentage Of Reduction In Employees PercentageOfReductionInEmployees	0.05
CY2023Q4	us-gaap	Severance Costs1 SeveranceCosts1	1820000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	3796000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	2268000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4704000
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	904000
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1192000
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	618000
CY2021	us-gaap	Restructuring Charges RestructuringCharges	4704000
CY2021	us-gaap	Payments For Restructuring PaymentsForRestructuring	2154000
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	3168000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	2268000
CY2022	us-gaap	Payments For Restructuring PaymentsForRestructuring	4244000
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	1192000
CY2023	us-gaap	Restructuring Charges RestructuringCharges	3796000
CY2023	us-gaap	Payments For Restructuring PaymentsForRestructuring	4084000
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	904000
CY2023Q4	us-gaap	Secured Debt SecuredDebt	66563000
CY2022Q4	us-gaap	Secured Debt SecuredDebt	71250000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	332000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	481000
CY2023Q4	orgo	Secured Debt Net SecuredDebtNet	66231000
CY2022Q4	orgo	Secured Debt Net SecuredDebtNet	70769000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5625000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	6563000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	54375000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	66563000
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	0
CY2023Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	9340046
CY2022Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	5931742
CY2023Q4	orgo	Sharesreservedforissuanceforoutstandingrestrictedstockunits Sharesreservedforissuanceforoutstandingrestrictedstockunits	3898331
CY2022Q4	orgo	Sharesreservedforissuanceforoutstandingrestrictedstockunits Sharesreservedforissuanceforoutstandingrestrictedstockunits	1381500
CY2023Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	4898964
CY2022Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	11394962
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18137341
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	18708204
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3554528
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1418224
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0192
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.51
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5066
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	2.47
CY2022Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	7.87
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.94
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5931742
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.91
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M20D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2245000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3554528
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	146224
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.09
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9340046
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.6
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M28D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10267000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3999380
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.57
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y29D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4681000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8488262
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.66
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y5M8D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	9227000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3117000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2082000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1275000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	178000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2157000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2575000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	899000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	17000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-39000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3435000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2770000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	860000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3311000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	5446000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-30506000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1312000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3466000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1470000
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	13000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2012000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1980000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31976000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5447000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4750000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-31116000
CY2021	orgo	Change In Valuation Allowance ChangeInValuationAllowance	-48252000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2455000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	9327000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	665000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	960000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	4000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	16000
CY2023Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	6404000
CY2022Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	5658000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	17608000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	8849000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1699000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1453000
CY2022Q4	orgo	Deferred Tax Assets Finance Leases DeferredTaxAssetsFinanceLeases	126000
CY2023Q4	orgo	Deferredtaxassetsoperatingleases Deferredtaxassetsoperatingleases	12503000
CY2022Q4	orgo	Deferredtaxassetsoperatingleases Deferredtaxassetsoperatingleases	13164000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3921000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41338000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43474000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1493000
CY2023Q4	orgo	Deferredtaxliabilitiesrightofuseassets Deferredtaxliabilitiesrightofuseassets	10002000
CY2022Q4	orgo	Deferredtaxliabilitiesrightofuseassets Deferredtaxliabilitiesrightofuseassets	10724000
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-1841000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-2736000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	28002000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	30014000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.706
CY2021	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.091
CY2023	orgo	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	-0.014
CY2022	orgo	Effective Income Tax Rate Reconciliation Return To Provision And Other Adjustments Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionAndOtherAdjustmentsPercent	-0.016
CY2022	orgo	Effective Income Tax Rate Reconciliation Prior Period Correction Percent EffectiveIncomeTaxRateReconciliationPriorPeriodCorrectionPercent	-0.085
CY2023	orgo	Effective Income Tax Rate Reconciliation Executive Compensation Percent EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent	0.12
CY2022	orgo	Effective Income Tax Rate Reconciliation Executive Compensation Percent EffectiveIncomeTaxRateReconciliationExecutiveCompensationPercent	0.031
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.088
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.068
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.068
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Meals And Entertainment EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment	0.059
CY2023	orgo	Effective Income Tax Rate Reconciliation Nondeductible Expense Lobbying Expense Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLobbyingExpensePercent	0.017
CY2022	orgo	Effective Income Tax Rate Reconciliation Nondeductible Expense Lobbying Expense Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLobbyingExpensePercent	0.004
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.013
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.003
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.001
CY2023	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.007
CY2022	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.003
CY2021	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.009
CY2023	orgo	Effective Income Tax Rate Reconciliation Nondeductible Expense Fringe Benefits Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFringeBenefitsPercent	0.01
CY2022	orgo	Effective Income Tax Rate Reconciliation Nondeductible Expense Fringe Benefits Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseFringeBenefitsPercent	0.004
CY2023	orgo	Effective Income Tax Rate Reconciliation State Tax Credit Percent EffectiveIncomeTaxRateReconciliationStateTaxCreditPercent	0.011
CY2022	orgo	Effective Income Tax Rate Reconciliation State Tax Credit Percent EffectiveIncomeTaxRateReconciliationStateTaxCreditPercent	0.009
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.008
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.009
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.524
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.234
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.493
CY2023	orgo	Description Of Recognized Tax Benefits Upon Ultimate Settlement DescriptionOfRecognizedTaxBenefitsUponUltimateSettlement	The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2837000
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2642000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2307000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1632000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1612000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2123000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	113000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	206000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	153000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	126000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	186000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	664000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1619000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1632000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1612000
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	500000
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	404000
CY2023	us-gaap	Profit Loss ProfitLoss	4945000
CY2022	us-gaap	Profit Loss ProfitLoss	15532000
CY2021	us-gaap	Profit Loss ProfitLoss	94202000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131231317
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	130070231
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	128331022
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132746727
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	132383152
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133662659
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.73
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.7
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3147503
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3445191
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	994168
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-559000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	479000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	213000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	137000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000
CY2023	orgo	Finance Lease Cost FinanceLeaseCost	616000
CY2022	orgo	Finance Lease Cost FinanceLeaseCost	220000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	10052000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9570000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2921000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2951000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	5595000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	5082000
CY2023	us-gaap	Lease Cost LeaseCost	19184000
CY2022	us-gaap	Lease Cost LeaseCost	17823000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	3454000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1174000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	479000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1174000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2975000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1081000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1888000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2969000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	10401000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	9273000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	137000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	7000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	485000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	200000
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M29D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y5M26D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M14D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0791
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0471
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0461
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	9799000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Next Rolling Twelve Months FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths	1278000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	8823000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Two FinanceLeaseLiabilityPaymentsDueInRollingYearTwo	1278000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	7542000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due In Rolling Year Three FinanceLeaseLiabilityPaymentsDueInRollingYearThree	737000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	13275000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	3570000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	15108000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	58117000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3293000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7966000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	324000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	50151000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	2969000
CY2023Q4	us-gaap	Other Commitment OtherCommitment	34915000
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	7430000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	6601000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	3092000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-24-023150-index-headers.html	Edgar Link	pending
0000950170-24-023150-index.html	Edgar Link	pending
0000950170-24-023150.txt	Edgar Link	pending
0000950170-24-023150-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img153933632_0.jpg	Edgar Link	pending
img153933632_1.jpg	Edgar Link	pending
img153933632_10.jpg	Edgar Link	pending
img153933632_11.jpg	Edgar Link	pending
img153933632_12.jpg	Edgar Link	pending
img153933632_13.jpg	Edgar Link	pending
img153933632_14.jpg	Edgar Link	pending
img153933632_15.jpg	Edgar Link	pending
img153933632_16.jpg	Edgar Link	pending
img153933632_17.jpg	Edgar Link	pending
img153933632_18.jpg	Edgar Link	pending
img153933632_19.jpg	Edgar Link	pending
img153933632_2.jpg	Edgar Link	pending
img153933632_20.jpg	Edgar Link	pending
img153933632_21.jpg	Edgar Link	pending
img153933632_22.jpg	Edgar Link	pending
img153933632_23.jpg	Edgar Link	pending
img153933632_24.jpg	Edgar Link	pending
img153933632_25.jpg	Edgar Link	pending
img153933632_26.jpg	Edgar Link	pending
img153933632_3.jpg	Edgar Link	pending
img153933632_4.jpg	Edgar Link	pending
img153933632_5.jpg	Edgar Link	pending
img153933632_6.jpg	Edgar Link	pending
img153933632_7.jpg	Edgar Link	pending
img153933632_8.jpg	Edgar Link	pending
img153933632_9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orgo-20231231.htm	Edgar Link	pending
orgo-20231231.xsd	Edgar Link	pending
orgo-ex21_1.htm	Edgar Link	pending
orgo-ex23_1.htm	Edgar Link	pending
orgo-ex31_1.htm	Edgar Link	pending
orgo-ex31_2.htm	Edgar Link	pending
orgo-ex32_1.htm	Edgar Link	pending
orgo-ex97_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
orgo-20231231_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGO
Organogenesis Holdings Inc. Stock $orgo

2024 Q1 Form 10-K Financial Statement

#000095017024023150 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO Organogenesis Holdings Inc. Stock $orgo

2024 Q1 Form 10-K Financial Statement

#000095017024023150 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO
Organogenesis Holdings Inc. Stock $orgo